Alpha 2.0
Login Register
» Articles » PMID: 11819223

Aflatoxin Sufferer and P53 Gene Mutation in Hepatocellular Carcinoma

Overview
Journal World J Gastroenterol
Publisher Baishideng Publishing Group
Specialty Gastroenterology
Date 2002 Jan 31
PMID 11819223
Citations 21
Authors
Zhuo-lin Deng
Yun Ma
Affiliations
Soon will be listed here.
Abstract

AIM:To study the p53 gene mutation and its relationship to aflatoxin B1 exposure in hepatocellular carcinoma (HCC).METHODS: Restriction fragment length polymorphism analysis method was used in 62 HCC samples, and DNA direct sequencing in another 45 HCC samples.RESULTS: In HCC and AFB1 high and low-risk areas, 36/52 (69%) and 2/10 (20%) cases were found losing the HaeIII allele respectively, suggesting one of the base G mutation at the p53 gene codon 249. Similar results appeared in DNA direct sequencing, 20/35 (57%) and 1/10 (10%) respectively mutated at the codon 249 third base G to C transversion.CONCLUSION: In HCC after AFB1 exposure, mutation of p53 gene is fixed at codon 249 third base and take the form of G to T transversion. This is a definite marker of mutation which is induced by AFB1 mutagen. It is applicable for molecular epidemiologic survey of the sufferers of AFB1 among HCC cases and for discovering more unknown natural AFB1 contaminated areas.

Citing Articles

Aflatoxin B induces infertility, fetal deformities, and potential therapies.

Francis S, Kortei N, Sackey M, Richard S Open Med (Wars). 2024; 19(1):20240907.

PMID: 38283584 PMC: 10818061. DOI: 10.1515/med-2024-0907.

Fungal infections and the fungal microbiome in hepatobiliary disorders.

Hartmann P, Schnabl B J Hepatol. 2022; 78(4):836-851.

PMID: 36565724 PMC: 10033447. DOI: 10.1016/j.jhep.2022.12.006.

The Effect of Aflatoxin B1 on Tumor-Related Genes and Phenotypic Characters of MCF7 and MCF10A Cells.

Ahmed Adam M, Kamal L, Kanakal M, Babu D, Dahham S, Tabana Y Int J Mol Sci. 2022; 23(19).

PMID: 36233156 PMC: 9570345. DOI: 10.3390/ijms231911856.

Poly(ADP-Ribose) Polymerase Inhibition as a Promising Approach for Hepatocellular Carcinoma Therapy.

Paturel A, Hall J, Chemin I Cancers (Basel). 2022; 14(15).

PMID: 35954469 PMC: 9367559. DOI: 10.3390/cancers14153806.

The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance.

Thi Ngo M, Jeng H, Kuo Y, Nanda J, Brahmadhi A, Ling T Int J Mol Sci. 2021; 22(4).

PMID: 33669204 PMC: 7919800. DOI: 10.3390/ijms22041931.

References
1.
Hsu I, Metcalf R, Sun T, Welsh J, Wang N, Harris C . Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991; 350(6317):427-8. DOI: 10.1038/350427a0. View
2.
Fujimoto Y, Hampton L, Wirth P, Wang N, Xie J, Thorgeirsson S . Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res. 1994; 54(1):281-5. View
3.
Li D, Cao Y, He L, Wang N, Gu J . Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis. 1993; 14(2):169-73. DOI: 10.1093/carcin/14.2.169. View
4.
Bressac B, Kew M, Wands J, Ozturk M . Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991; 350(6317):429-31. DOI: 10.1038/350429a0. View
5.
Yeh F, Yu M, Mo C, Luo S, Tong M, Henderson B . Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 1989; 49(9):2506-9. View